Research
Metabolic adaptation
Tirzepatide increases insulin secretion, reduces glucagon release, decreases fasting and postprandial glucose levels, promotes satiety, decreases body weight, and delays gastric emptying.
Tirzepatide can help manage blood sugar levels and weight in patients with type 2 diabetes.
StrongSupportsmedium confidence
Tirzepatide increases insulin secretion, reduces glucagon release in a glucose-dependent manner, decreases fasting and postprandial glucose levels, promotes satiety, decreases body weight, and delays gastric emptying.
Why this rating
Supported by clinical trial data mentioned in the abstract.
Source
Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus
Elaine Wong et al. · American Journal of Therapeutics · 2022
reviewCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →